| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM197806222982503 |
| P953 | full work available at URL | http://www.nejm.org/doi/pdf/10.1056/NEJM197806222982503 |
| P698 | PubMed publication ID | 349387 |
| P50 | author | Paolo De Simone | Q90694945 |
| P2093 | author name string | E. Kim | |
| D. M. Goldenberg | |||
| J. R. van Nagell | |||
| van Nagell JR Jr | |||
| S. Bennett | |||
| P. Rayburn | |||
| F. J. Primus | |||
| N. Estes | |||
| F. DeLand | |||
| P2860 | cites work | Journal of the National Cancer Institute | Q400279 |
| Proceedings of the American Association for Cancer Research | Q27717904 | ||
| Identification of an antigen from normal human tissue that crossreacts with the carcinoembryonic antigen | Q34727061 | ||
| VASCULAR RELATIONSHIPS OF TUMOR AND HOST. | Q35441490 | ||
| Specific carcinoembryonic antigens of the human digestive system | Q36267788 | ||
| The history and progress of serologic immunotherapy and radiodiagnosis | Q39357640 | ||
| Oncofetal and Other Tumor-Associated Antigens of the Human Digestive System | Q39416765 | ||
| Tumor scanning agents | Q39870859 | ||
| The present status of DEA in diagnosis, prognosis, and evaluation of therapy | Q40468149 | ||
| Radionuclide Imaging of Metastases from Renal-Cell Carcinoma by131I-labeled Antitumor Antibody | Q43783455 | ||
| Trial of radiolabeled antibody localization in metastases of a patient with a tumor containing carcinoembryonic antigen (CEA). | Q47830304 | ||
| Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer | Q47892014 | ||
| Carcinoembryonic antigenic activity of tissue extracts: A quantitative study of malignant and benign neoplasms, cirrhotic liver, normal adult and fetal organs | Q47913951 | ||
| Carcinoembryonic antigen in histopathology: immunoperoxidase staining of conventional tissue sections | Q48379854 | ||
| Immunochemotherapy of Cancer with Chlorambucil-carrying Antibody | Q54479667 | ||
| Briel Communication : Location by Immunoelectron Microscopy of Carcinoembryonic Antigen on Cultured Adenocarcinoma Cells 2 | Q67326916 | ||
| Human Anti-CEA Antibodies detected by Radioimmunoelectrophoresis | Q69004461 | ||
| A method of trace iodination of proteins for immunologic studies | Q70063670 | ||
| Radiolabeled antibodies | Q74727764 | ||
| Studies directed toward the use of antibodies as carriers of radioactivity for therapy | Q74843938 | ||
| Electric enhancement of bone healing | Q95778881 | ||
| P433 | issue | 25 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| Immunologic Technique | Q73400755 | ||
| P304 | page(s) | 1384-1386 | |
| P577 | publication date | 1978-06-01 | |
| 1978-06-22 | |||
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External Photoscanning | |
| P478 | volume | 298 |
| Q64993130 | A Comprehensive Review on Current Advances in Peptide Drug Development and Design. |
| Q72747691 | A monoclonal antibody against a CEA-related antigen expressed on HT29 colon tumour cells |
| Q38205738 | A perspective of monoclonal antibodies: past, present, and future |
| Q69586044 | A preliminary pharmacokinetic study of 111In-labeled 260F9 anti-(breast cancer) antibody in patients |
| Q43532814 | A rapid method for the determination of human CEA/mouse anti-CEA immune complexes in patients undergoing immunoscintigraphy |
| Q37169112 | A re-examination of radioimmunotherapy in the treatment of non-Hodgkin lymphoma: prospects for dual-targeted antibody/radioantibody therapy. |
| Q90754603 | A systems approach to clinical oncology uses deep phenotyping to deliver personalized care |
| Q33659818 | A thousand points of light or just dim bulbs? Radiolabeled antibodies and colorectal cancer imaging |
| Q41490919 | A vindesine-anti-CEA conjugate cytotoxic for human cancer cells in vitro |
| Q68810259 | Accurate quantification of 131I distribution by gamma camera imaging |
| Q57826559 | Adamantane/Cucurbituril: A Potential Pretargeted Imaging Strategy in Immuno-PET |
| Q70723988 | Advances in the diagnostic imaging of cancer |
| Q70974973 | Anti-oncofoetal proteins for targeting cytotoxic drugs |
| Q33933425 | Antibodies as delivery systems for diagnostic functions |
| Q40149416 | Antibodies to Fetal Antigens Associated with Rodent Tumours |
| Q40912787 | Antibody-directed enzyme prodrug therapy (ADEPT). |
| Q40810462 | Antibody-guided scintigraphy: targeting of the "magic bullet". |
| Q39740848 | Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview |
| Q40157369 | Antitumor monoclonal antibodies for radioimmunodetection of tumors and drug targeting |
| Q40872306 | Biochemical markers for colorectal cancer. Diagnostic and therapeutic implications |
| Q41647491 | Biodistribution of radiolabeled monoclonal antibody after intraperitoneal administration in nude mice with hepatic metastasis from human colon cancer |
| Q38206206 | Bioorthogonal chemistry: implications for pretargeted nuclear (PET/SPECT) imaging and therapy |
| Q69781497 | Breast cancer imaging with mouse monoclonal antibodies |
| Q78174583 | Breast cancer imaging with radiolabeled antibodies |
| Q39817736 | CEA-related antigens: molecular biology and clinical significance |
| Q39552434 | Can postoperative surveillance with serial CEA immunoscintigraphy detect resectable rectal cancer recurrence and potentially improve tumor-free survival? |
| Q54441492 | Cancer drug targeting. |
| Q35070045 | Cancer radioimmunotherapy |
| Q38334781 | Carbohydrates engineered at antibody constant domains can be used for site-specific conjugation of drugs and chelates |
| Q41621278 | Carbon Dots-AS1411 Aptamer Nanoconjugate for Ultrasensitive Spectrofluorometric Detection of Cancer Cells. |
| Q41094091 | Carcinoembryonic antigen in carcinoma of the uterine cervix2. Tissue localization and correlation with plasma antigen concentration |
| Q72917318 | Carcinoembryonic antigen in carcinoma of the uterine cervix: Antigen distribution in primary and metastatic tumors |
| Q67256039 | Carcinoembryonic antigen radioimmunodetection in the evaluation of colorectal cancer and in the detection of occult neoplasms |
| Q72539799 | Case for adoptive immunotherapy in cancer |
| Q41492340 | Cellular distribution of monoclonal antibody in human tumours after i.v. administration |
| Q36326582 | Characterization of genetically modified T-cell receptors that recognize the CEA:691-699 peptide in the context of HLA-A2.1 on human colorectal cancer cells |
| Q72079960 | Characterization of second-generation monoclonal antibodies against carcinoembryonic antigen |
| Q64905245 | Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic Approaches. |
| Q40916868 | Clinical applications of indium-111-labeled monoclonal antibody imaging in colorectal cancer patients |
| Q40936198 | Clinical evaluation of tumor targeting with the anticarcinoembryonic antigen murine monoclonal antibody fragment, MN-14 F(ab)2. |
| Q72609276 | Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein |
| Q44770923 | Clinical uses of monoclonal antibodies |
| Q68085163 | Comparison of the iodogen and the microelectrochemical techniques for the radioiodination of monoclonal antibody 140.240 |
| Q72308782 | Concentration and distribution of tumor associated antigens TAG-72 and CEA in stomach cancer |
| Q36684500 | Current results and future applications of radioimmunotherapy management of non-Hodgkin's lymphoma |
| Q39655728 | Current status of cancer imaging with radiolabeled antibodies |
| Q36812218 | Detection and localization of ovarian cancer with radiolabeled monoclonal antibodies |
| Q34519921 | Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies |
| Q43706134 | Detection of hepatic metastases from colorectal carcinoma using indium-111 (111In) labeled monoclonal antibody (mAB): MSKCC experience with mAb 111In-C110 |
| Q45343693 | Diagnosis and treatment of neoplasms with radionuclide-labeled antibodies |
| Q39995078 | Different biodistribution of 99mTc-labelled chimeric mouse-human monoclonal antibody between athymic mice model and human |
| Q73127529 | Distribution of radiolabelled anti-CA125 monoclonal antibody OC125-F(ab)2-fragment following resection guided by antibodies (REGAJ) in ovarian cancer patients |
| Q36050826 | Does immunoscintigraphy serve clinical needs effectively? Is there a future for radioimmunotherapy? |
| Q35674675 | Early diagnosis of ovarian cancer |
| Q41191675 | Effect of Cross-Reactivity of Alpha-Fetoprotein Monoclonal Antibody on Quantitation of Serum AFP and Radioimmunodetection of Hepatocellular Carcinoma |
| Q57911948 | Emerging classes of armed antibody therapeutics against cancer |
| Q24792155 | Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancers |
| Q38702695 | Future role of radiolabeled monoclonal antibodies in oncological diagnosis and therapy |
| Q41098116 | General anatomy of the lymphatic system. |
| Q34451877 | Genetically engineered antibodies for direct antineoplastic treatment and systematic delivery of various therapeutic agents to cancer cells |
| Q37230505 | High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment |
| Q69530033 | Histological correlation of 17 prospective immunoscintigraphies of recurrences of colorectal carcinomas using indium-111-labeled anti-cea and(or) 19-9 monoclonal antibodies |
| Q40135047 | Human Chorionic Gonadotropin as a Model for a Fetal Antigen |
| Q67953121 | Human breast tumor imaging using 111In labeled monoclonal antibody: athymic mouse model |
| Q36384496 | Human chorionic gonadotropin radioantibodies in the radioimmunodetection of cancer and for disclosure of occult metastases |
| Q40105074 | Human tumor-associated antigens identified by monoclonal antibodies |
| Q57337268 | INDIUM-111 LABELLED MONOCLONAL ANTIBODY TO PLACENTAL ALKALINE PHOSPHATASE IN THE DETECTION OF NEOPLASMS OF TESTIS, OVARY, AND CERVIX |
| Q40855094 | Imaging lung cancer with radiolabeled antibodies |
| Q38702672 | Imaging of colorectal carcinoma with radiolabeled antibodies |
| Q40916864 | Imaging of colorectal carcinoma with technetium-99m radiolabeled Fab' fragments |
| Q38672137 | Imaging with radiolabelled monoclonal antibodies |
| Q84516421 | Immuno-SPET/CT and immuno-PET/CT: a step ahead to translational imaging |
| Q41667349 | Immunodetection of thyroid tumors: role of immuno aggregates |
| Q70150097 | Immunodiagnosis of tumors in vivo using radiolabeled monoclonal antibody A2B5 |
| Q36290911 | Immunohistochemical identification of CA125 and the F(ab')2 fragments of the murine monoclonal antibody OC125 in ovarian cancer tissue |
| Q41348630 | Immunolocalization of hepatic metastases of human colonic cancer by chimeric anti-TAG72 antibody in SCID mice |
| Q64948861 | Immunoscopy--a technique combining endoscopy and immunofluorescence for diagnosis of colorectal carcinoma. |
| Q69963686 | Immunotargeting in the diagnosis and treatment of liver cancer |
| Q40976323 | Improved cancer therapy and molecular imaging with multivalent, multispecific antibodies |
| Q68364477 | Improved radioimmunolocalization of human tumor xenografts following subcutaneous delivery of monoclonal antibodies |
| Q42818344 | Improved tumour localisation using indium-111 labelled antibodies. |
| Q53393202 | Induction of an immune response through the idiotypic network with monoclonal anti‐idiotype antibodies in the carcinoembryonic antigen system |
| Q41711473 | Induction of carcinoembryonic-antigen-gene expression in human colorectal carcinoma by sodium butyrate |
| Q90315420 | Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer |
| Q46355320 | Intraoperative detection of occult colon cancer micrometastases using 125 I-radiolabled monoclonal antibody CC49. |
| Q36050008 | Introduction to monoclonal antibodies |
| Q43972582 | Is anti-alphafetoprotein immunoscintigraphy a promising approach for the diagnosis of hepatoma? Implications of a quantitative study in 41 patients |
| Q55488484 | Is there a role for radioimmunolocalization in diagnosis of intracranial malignancies?: discussion paper. |
| Q24610708 | Isolation and characterization of cDNA clones encoding the human carcinoembryonic antigen reveal a highly conserved repeating structure |
| Q72533248 | Liposomally entrapped second antibody improves tumour imaging with radiolabelled (first) antitumour antibody |
| Q34783921 | Localisation of malignant germ-cell tumours by external scanning after injection of radiolabelled anti-alpha-fetoprotein |
| Q71353244 | Localisation of tumour deposits by external scanning after injection of radiolabelled anti-carcinoembryonic antigen |
| Q35208368 | Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy |
| Q44857967 | Localization of human breast tumors grafted in nude mice with a monoclonal antibody directed against a defined cell surface antigen of human mammary epithelial cells |
| Q36045212 | Localization of human breast-carcinoma xenografts using antibodies to carcinoembryonic antigen |
| Q41487635 | Localization of human tumour xenografts after i.v. administration of radiolabeled monoclonal antibodies |
| Q72564761 | Location of metastatic breast carcinoma by a monoclonal antibody chelate labelled with indium-111 |
| Q39661825 | Low antigen density tumor cells: an obstacle to effective autologous bone marrow purging? |
| Q70327652 | Metabolizable 111In chelate conjugated anti-idiotype monoclonal antibody for radioimmunodetection of lymphoma in mice |
| Q70110215 | Monoclonal antibodies and hepatoma |
| Q40248951 | Monoclonal antibodies and human tumor pathology |
| Q37508647 | Monoclonal antibodies in imaging and therapy of colorectal cancer |
| Q40916840 | Monoclonal antibodies in ovarian and prostate cancer |
| Q40201565 | Monoclonal antibodies in the treatment of cancer |
| Q42852756 | Monoclonal antibodies to detect human tumours: an experimental approach |
| Q38670749 | Monoclonal antibodies: clinical applications |
| Q38215737 | Monoclonal antibodies: their importance to surgeons |
| Q69014364 | N-hydroxysuccinimide-hippuran ester: application for radiolabeling of macro-molecules |
| Q36294954 | Neutron-capture therapy of human cancer: in vitro results on the preparation of boron-labeled antibodies to carcinoembryonic antigen |
| Q36247868 | Neutron-capture therapy of human cancer: in vivo results on tumor localization of boron-10-labeled antibodies to carcinoembryonic antigen in the GW-39 tumor model system |
| Q34130569 | New approaches to antibody therapy |
| Q35588271 | New diagnostic imaging in rectal cancer: endosonography and immunoscintigraphy |
| Q68808872 | Non-human primate (baboon) anti-carcinoembryonic antigen antibody infusion in patients with metastatic adenocarcinoma. A phase I study |
| Q34631801 | Novel radiolabeled antibody conjugates |
| Q40938905 | Nuclear medicine at the crossroads |
| Q40112014 | Nuclear oncology 1984. |
| Q36945653 | Operative probe scintimetry with indium and technetium for colorectal cancer |
| Q38149131 | Peptides in receptor-mediated radiotherapy: from design to the clinical application in cancers |
| Q93631719 | Pharmacokinetic study of radiolabeled anti-colorectal carcinoma monoclonal antibodies in tumor-bearing nude mice |
| Q72875901 | Phase I–II study of radiolabeled antibody integrated in the treatment of primary hepatic malignancies |
| Q70800950 | Physical Test for Distant Metastases in Patients with Breast Cancer |
| Q34277286 | Positron emission tomography (PET) and other nuclear medicine modalities in staging gastrointestinal cancer |
| Q39414818 | Positron emission tomography of 64Cu-DOTA-Rituximab in a transgenic mouse model expressing human CD20 for clinical translation to image NHL. |
| Q38157384 | Potential applications of monoclonal antibodies in cancer diagnosis and therapy |
| Q41139389 | Pre-existing anti-mouse immunoglobulin in a patient receiving 131I-murine monoclonal antibody for radioimmunolocalisation |
| Q69749260 | Preliminary findings in the evaluation of hepatic malignancies by radioimmunodetection, X-ray computed tomography, and magnetic resonance imaging |
| Q44638568 | Preoperative imaging of colorectal cancers. Targeting the epithelial membrane antigen with a radiation-labeled monoclonal antibody |
| Q38022016 | Pretargeted molecular imaging and radioimmunotherapy |
| Q40517227 | Problems of delivery of monoclonal antibodies. Pharmaceutical and pharmacokinetic solutions |
| Q41561062 | Production of a bifunctional hybrid molecule B72.3/metallothionein-1 by protein engineering. |
| Q27023605 | Quantitative in vivo cell-surface receptor imaging in oncology: kinetic modeling and paired-agent principles from nuclear medicine and optical imaging |
| Q37796519 | Radioactive Antibodies: A Historical Review of Selective Targeting and Treatment of Cancer |
| Q37955250 | Radioantibodies for the diagnosis and treatment of cancer; radioimmunoimaging (RAI) and radioimmunotherapy (RAT). |
| Q41731604 | Radioimaging of human glioma xenografts with 123I labeled monoclonal antibody G-22 against glioma-associated antigen |
| Q38691472 | Radioimmunoconjugates for treating cancer: recent advances and current opportunities |
| Q40191560 | Radioimmunodetection and radioimmunotherapy |
| Q72726962 | Radioimmunodetection of cancer using antibodies to alpha-fetoprotein and carcinoembryonic antigen |
| Q42855761 | Radioimmunodetection of cancer: problems and potential |
| Q72530917 | Radioimmunodetection of human colorectal cancers by an anti-tumour monoclonal antibody |
| Q55383265 | Radioimmunodetection with 111In-labeled monoclonal antibody Nd2 in patients with pancreatic cancer. |
| Q41092135 | Radioimmunoguided surgery and colorectal cancer. |
| Q36096813 | Radioimmunoimaging with longer-lived positron-emitting radionuclides: potentials and challenges. |
| Q70800954 | Radioimmunolocalization of Tumours by External Scintigraphy after Administration of131I Antibody to Human Chorionic Gonadotrophin: Preliminary Communication |
| Q67819999 | Radioimmunolocalization of colorectal carcinoma. A correlation among RIL results, surgical findings, serum tumor marker levels and the presence of CEA and CA 19.9 in tumor tissue: The experience of the Hospital de la Santa Creu i Sant Pau |
| Q41362359 | Radioimmunolocalization of human brain tumours: biodistribution of radiolabelled monoclonal antibody UJ13A. |
| Q68462305 | Radioimmunolocation of metastases from adenocarcinoma of the colon: using a hepatoma antibody |
| Q41557305 | Radioimmunoscintigraphy of advanced gastrointestinal carcinomas employing I-131 labeled CEA-79 monoclonal antibody |
| Q69948286 | Radioimmunoscintigraphy of ovarian cancer with 131-iodine labeled OC-125 antibody fragments |
| Q42779276 | Radioimmunotechnology for cancer diagnosis and treatment. |
| Q67488314 | Radioiodinated anti-hepatocellular carcinoma (HCC) ferritin. Targeting therapy, tumor imaging and anti-antibody response in HCC patients with hepatic arterial infusion |
| Q47114491 | Radiolabeled Anti-Adenosine Triphosphate Synthase Monoclonal Antibody as a Theragnostic Agent Targeting Angiogenesis |
| Q46538198 | Radiolabeled antibody imaging in the management of colorectal cancer. Results of a multicenter clinical study |
| Q38702668 | Radiolabeled monoclonal antibodies in the diagnosis and treatment of malignant melanoma |
| Q69018361 | Radiolabelled monoclonal antibodies against alpha-fetoprotein for in vivo localization of human hepatocellular carcinoma by immunotomoscintigraphy |
| Q40143838 | Radiolabelled monoclonal antibodies: A new diagnostic tool in nuclear medicine |
| Q37207310 | Radionuclide-Based Cancer Imaging Targeting the Carcinoembryonic Antigen. |
| Q98164567 | Radiopharmaceutical therapy in cancer: clinical advances and challenges |
| Q33992130 | Radiopharmaceutical therapy in the era of precision medicine |
| Q41209526 | Radiopharmaceutical-related pitfalls and artifacts |
| Q40813136 | Recent achievements in the development of radiolabeled monoclonal antibodies for diagnosis, therapy and biologic characterization of human tumors |
| Q50122731 | Recent advances in detection of metastatic testicular cancer |
| Q36008285 | Receptor-mediated tumor targeting with radiopeptides. Part 1. General concepts and methods: applications to somatostatin receptor-expressing tumors |
| Q37515337 | Receptor-mediated tumor targeting with radiopeptides. Part 1. General principles and methods |
| Q37720857 | Recombinant bispecific monoclonal antibodies prepared by the dock-and-lock strategy for pretargeted radioimmunotherapy |
| Q36407480 | Review of clinical radioimmunotherapy |
| Q55387466 | Scanning for tumours with radiolabelled antibodies: a review. |
| Q68196332 | Scintigraphic detection of gastric and pancreatic carcinomas with In-111 ZCE 025 monoclonal antibody |
| Q72659191 | Scintigraphy and distribution of labeled antibodies in rats with tumors |
| Q36259617 | Second antibody clearance of radiolabeled antibody in cancer radioimmunodetection |
| Q78465073 | Second antibody for improvement of antibody imaging: liposome-entrapped and free preparations in animal and human studies |
| Q25256754 | Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein |
| Q35610820 | Selective modification of NMR relaxation time in human colorectal carcinoma by using gadolinium-diethylenetriaminepentaacetic acid conjugated with monoclonal antibody 19-9. |
| Q81419944 | Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibody |
| Q36061079 | Simultaneous Detection of α-Fetoprotein and Carcinoembryonic Antigen Based on Si Nanowire Field-Effect Transistors |
| Q90550172 | Site-specific chelator-antibody conjugation for PET and SPECT imaging with radiometals |
| Q73954600 | Site-specific conjugation on serine right-arrow cysteine variant monoclonal antibodies |
| Q35600422 | Site-specific covalent modification of monoclonal antibodies: in vitro and in vivo evaluations |
| Q71572240 | Syngeneic anti-idiotypic antibodies eliminate excess radiolabeled idiotypes at experimental radioimmunolocalization |
| Q73484684 | Synthesis of aminobenzyltriethylenetetraaminohexaacetic acid: conjugation of the chelator to protein by an alkylamine linkage |
| Q40108222 | Targeting to lymphoid cells of the immune network |
| Q50122664 | The applications of xenografts in the study of human germ cell tumours |
| Q36028794 | The clinical value of imaging with antibody to human chorionic gonadotrophin in the detection of residual choriocarcinoma |
| Q71001047 | The detection of squamous cell tumours of the head and neck using radio-labelled antibodies |
| Q42372879 | The effect of circulating antigen and radiolabel stability on the biodistribution of an indium labelled antibody |
| Q36467469 | The effect of serum CEA on the distribution and clearance of anti-CEA antibody in a pancreatic tumour xenograft model |
| Q70644608 | The effect of specimen processing on radiolabeled monoclonal antibody biodistribution |
| Q36903804 | The emerging role of molecular imaging and targeted therapeutics in peritoneal carcinomatosis |
| Q41148664 | The localization of anti-tumour monoclonal antibodies in colorectal cancer. |
| Q41418638 | The localization of human breast carcinomas by radiolabelled monoclonal antibodies |
| Q38072815 | The new golden era for radioimmunotherapy: not just for lymphomas anymore |
| Q34288933 | The role of radiolabeled antibodies in the treatment of non-Hodgkin's lymphoma: the coming of age of radioimmunotherapy |
| Q46696156 | The use of a monoclonal antibody against alpha-fetoprotein for the radioimmunodetection of hepatocellular carcinoma |
| Q39698582 | Therapeutic implications of patterns of recurrence in cancer of the uterine cervix |
| Q36047986 | Third Gordon Hamilton-Fairley Memorial Lecture. Tumour markers—Where do we go from here? |
| Q41418377 | Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: first clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen |
| Q64080636 | Toxicity and pharmacokinetic profile of SGM-101, a fluorescent anti-CEA chimeric antibody for fluorescence imaging of tumors in patients |
| Q38979784 | Translating antibody directed enzyme prodrug therapy (ADEPT) and prospects for combination |
| Q39635115 | Treatment of transplanted tumor of lung adenocarcinoma A549 transfected by human somatostatin receptor subtype 2 (hsstr2) gene with 188Re-RC-160 |
| Q41937570 | Tumor Location Detected with Radioactively Labeled Monoclonal Antibody and External Scintigraphy |
| Q39689840 | Tumor detection using radiolabeled monoclonal antibodies |
| Q40435814 | Tumor imaging with monoclonal antibodies |
| Q28083230 | Tumor immunotargeting using innovative radionuclides |
| Q46834796 | Tumor targeting carboxylesterase fused with anti-CEA scFv improve the anticancer effect with a less toxic dose of irinotecan |
| Q36043531 | Tumour markers in breast cancer |
| Q47214368 | Uptake of a monoclonal antibody against CEA (Tumak 431/31) in a human colon tumor (Co-112) xenografted in the nude mouse. Dependence on tumor size and injected dose |
| Q73922946 | Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancer |
| Q70484476 | Use of specific antibody for rapid clearance of circulating blood background from radiolabeled tumor imaging proteins |
| Q70525958 | Use of the radiolabeled murine monoclonal antibody, 111In-CYT-103, in the management of colon cancer |
| Q67602161 | Usefulness of immunoscintigraphy in the follow-up of surgically treated gastrointestinal carcinomas using 111In-labelled anti-CEA monoclonal antibodies |
| Q38014920 | Using antibodies to target cancer therapeutics |
| Q35148805 | What nuclear cardiology can learn from nuclear oncology |
Search more.